These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1852069)

  • 1. Secondary hyperparathyroidism and the immune system in chronic renal failure.
    Massry SG; Alexiewicz JM; Gaciong Z; Klinger M
    Semin Nephrol; 1991 Mar; 11(2):186-201. PubMed ID: 1852069
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma parathormone immunoheterogeneity in primary hyperparathyroidism and in secondary to chronic renal insufficiency].
    Mazzuoli GF; Scarda A; D'Erasmo E; Rizzo G; Cinotti AG; Bracci U; Micali F; Miano L
    Minerva Nefrol; 1974; 21(5):367-71. PubMed ID: 4467058
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological differences between primary and secondary hyperparathyroidism: studies by means of radioimmunological determination of plasma parathyroid hormone].
    Mazzuoli G; Scarda A; Coen G; Guglielmi G; D'Erasmo E; Rizzo G
    Boll Soc Ital Biol Sper; 1974 Aug; 50(15):1187-93. PubMed ID: 4458702
    [No Abstract]   [Full Text] [Related]  

  • 4. [T- and B-lymphocytes in patients with chronic renal failure and in recipients of cadaveric allokidneys during the immediate posttransplant period].
    Dzerzhinskaia II
    Biull Eksp Biol Med; 1979 Feb; 87(2):174-6. PubMed ID: 369635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone inhibits B cell proliferation: implications in chronic renal failure.
    Alexiewicz JM; Klinger M; Pitts TO; Gaciong Z; Linker-Israeli M; Massry SG
    J Am Soc Nephrol; 1990 Sep; 1(3):236-44. PubMed ID: 1966555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of impaired T cell function in hemodialysis patients: potential role for secondary hyperparathyroidism.
    Alexiewicz JM; Gaciong Z; Klinger M; Linker-Israeli M; Pitts TO; Massry SG
    Am J Nephrol; 1990; 10(6):495-501. PubMed ID: 2075908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is anemia of chronic renal failure related to secondary hyperparathyroidism?
    Podjarny E; Rathaus M; Korzets Z; Blum M; Zevin D; Bernheim J
    Arch Intern Med; 1981 Mar; 141(4):453-5. PubMed ID: 7212887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of secondary hyperparathyroidism.
    Slatopolsky E; Delmez JA
    Miner Electrolyte Metab; 1995; 21(1-3):91-6. PubMed ID: 7565472
    [No Abstract]   [Full Text] [Related]  

  • 9. T cells and B cells in chronic renal failure.
    Descamps-Latscha B; Chatenoud L
    Semin Nephrol; 1996 May; 16(3):183-91. PubMed ID: 8734461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell activation modified by parathyroid hormone (PTH) in patients with end-stage renal disease.
    Kaneko T; Osono E; Hayama N; Lino Y; Terashi A
    Clin Nephrol; 1997 Dec; 48(6):353-8. PubMed ID: 9438093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response in hemodialysis patients: is there any difference when low and high iPTH levels are compared?
    Tzanno-Martins C; Futata E; Jorgetti V; Duarte AJ
    Clin Nephrol; 2000 Jul; 54(1):22-9. PubMed ID: 10939753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid function in renal insufficiency.
    Corvilain J; Fuss M; De Backer M; Bergans A; Nys-Dewolf N; Manderlier T; Brauman H
    Adv Nephrol Necker Hosp; 1974; 4():171-84. PubMed ID: 4219992
    [No Abstract]   [Full Text] [Related]  

  • 13. [Regulation of the calcium-sensing receptor. Influence of secondary hyperparathyroidism].
    Fernández Martín JL; González Suárez I; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():7-11. PubMed ID: 12778846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of soluble CD23 antigen levels in hemodialysis patients: effect of 1.25 dihydroxyvitamin D3 and recombinant human erythropoietin treatment.
    Altun B; Erdem Y; Usalan C; Arici M; Haznedaroglu IC; Yasavul U; Turgan C; Caglar S; Kirazli S
    Clin Nephrol; 1999 Oct; 52(4):230-8. PubMed ID: 10543325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relation between parathormone and 1,25-dihydroxyvitamin D3 in chronic kidney failure].
    Sotorník I
    Vnitr Lek; 1997 Sep; 43(9):615-9. PubMed ID: 9750473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characteristics of lymphocytes in chronic renal failure: in vitro response to mitogens.
    Nanni Costa A; Feliciangeli G; Borgnino LC; Buscaroli A; Mosconi G; Scolari MP; Orsi C; Coli L; Jannelli S; Galanti S
    Life Support Syst; 1983; 1 Suppl 1():88-91. PubMed ID: 6336587
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic disturbances and levels of parathyroid hormone in uremic patients in replacement dialysis therapy.
    Angelini D; Carlini A; Mazzotta L; Mei E; Grassi R; Giusti R; Neri M; Fiorini I; Antonelli A
    Clin Nephrol; 1994 Oct; 42(4):246-50. PubMed ID: 7834917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune system dysregulation in uremia.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Zingraff J; Jungers P; Chatenoud L
    Semin Nephrol; 1994 May; 14(3):253-60. PubMed ID: 8036360
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulsatile-secretion of parathyroid hormone in patients with chronic renal failure.
    de Francisco AL; Amado JA; Cotorruelo JG; González M; de Castro SS; Canga E; de Bonis E; Ruiz JC; Arias M; Gonzalez-Macías J
    Clin Nephrol; 1993 Apr; 39(4):224-8. PubMed ID: 8491053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone and the cellular immune system.
    Shurtz-Swirski R; Shkolnik T; Shasha SM
    Nephron; 1995; 70(1):21-4. PubMed ID: 7617112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.